Cargando…
Extracellular vesicles in urologic malignancies—Implementations for future cancer care
Extracellular vesicles (EVs), a heterogeneous group of vesicles differing in size and shape, cargo content and function, are membrane‐bound and nano‐sized vesicles that could be released by nearly all variations of cells. EVs have gained considerable attention in the past decades for their functions...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6869217/ https://www.ncbi.nlm.nih.gov/pubmed/31469460 http://dx.doi.org/10.1111/cpr.12659 |
_version_ | 1783472383366004736 |
---|---|
author | Wu, Zhangsong Zhang, Zhiqiang Xia, Wuchao Cai, Jiajia Li, Yuqing Wu, Song |
author_facet | Wu, Zhangsong Zhang, Zhiqiang Xia, Wuchao Cai, Jiajia Li, Yuqing Wu, Song |
author_sort | Wu, Zhangsong |
collection | PubMed |
description | Extracellular vesicles (EVs), a heterogeneous group of vesicles differing in size and shape, cargo content and function, are membrane‐bound and nano‐sized vesicles that could be released by nearly all variations of cells. EVs have gained considerable attention in the past decades for their functions in modulating intercellular signalling and roles as potential pools for the novel diagnostic and prognostic biomarkers, as well as therapeutic targets in several cancers including urological neoplasms. In general, human and animal cells both can release distinct types of EVs, including exosomes, microvesicles, oncosomes and large oncosomes, and apoptotic bodies, while the content of EVs can be divided into proteins, lipids and nucleic acids. However, the lack of standard methods for isolation and detection platforms rein the widespread usage in clinical applications warranted furthermore investigations in the development of reliable, specific and sensitive isolation techniques. Whether and how the EVs work has become pertinent issues. With the aid of high‐throughput proteomics or genomics methods, a fully understanding of contents contained in EVs from urogenital tumours, beyond all doubt, will improve our ability to identify the complex genomic alterations in the process of cancer and, in turn, contribute to detect potential therapeutic target and then provide personalization strategy for patient. |
format | Online Article Text |
id | pubmed-6869217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68692172020-03-13 Extracellular vesicles in urologic malignancies—Implementations for future cancer care Wu, Zhangsong Zhang, Zhiqiang Xia, Wuchao Cai, Jiajia Li, Yuqing Wu, Song Cell Prolif Review Extracellular vesicles (EVs), a heterogeneous group of vesicles differing in size and shape, cargo content and function, are membrane‐bound and nano‐sized vesicles that could be released by nearly all variations of cells. EVs have gained considerable attention in the past decades for their functions in modulating intercellular signalling and roles as potential pools for the novel diagnostic and prognostic biomarkers, as well as therapeutic targets in several cancers including urological neoplasms. In general, human and animal cells both can release distinct types of EVs, including exosomes, microvesicles, oncosomes and large oncosomes, and apoptotic bodies, while the content of EVs can be divided into proteins, lipids and nucleic acids. However, the lack of standard methods for isolation and detection platforms rein the widespread usage in clinical applications warranted furthermore investigations in the development of reliable, specific and sensitive isolation techniques. Whether and how the EVs work has become pertinent issues. With the aid of high‐throughput proteomics or genomics methods, a fully understanding of contents contained in EVs from urogenital tumours, beyond all doubt, will improve our ability to identify the complex genomic alterations in the process of cancer and, in turn, contribute to detect potential therapeutic target and then provide personalization strategy for patient. John Wiley and Sons Inc. 2019-08-30 /pmc/articles/PMC6869217/ /pubmed/31469460 http://dx.doi.org/10.1111/cpr.12659 Text en © 2019 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Wu, Zhangsong Zhang, Zhiqiang Xia, Wuchao Cai, Jiajia Li, Yuqing Wu, Song Extracellular vesicles in urologic malignancies—Implementations for future cancer care |
title | Extracellular vesicles in urologic malignancies—Implementations for future cancer care |
title_full | Extracellular vesicles in urologic malignancies—Implementations for future cancer care |
title_fullStr | Extracellular vesicles in urologic malignancies—Implementations for future cancer care |
title_full_unstemmed | Extracellular vesicles in urologic malignancies—Implementations for future cancer care |
title_short | Extracellular vesicles in urologic malignancies—Implementations for future cancer care |
title_sort | extracellular vesicles in urologic malignancies—implementations for future cancer care |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6869217/ https://www.ncbi.nlm.nih.gov/pubmed/31469460 http://dx.doi.org/10.1111/cpr.12659 |
work_keys_str_mv | AT wuzhangsong extracellularvesiclesinurologicmalignanciesimplementationsforfuturecancercare AT zhangzhiqiang extracellularvesiclesinurologicmalignanciesimplementationsforfuturecancercare AT xiawuchao extracellularvesiclesinurologicmalignanciesimplementationsforfuturecancercare AT caijiajia extracellularvesiclesinurologicmalignanciesimplementationsforfuturecancercare AT liyuqing extracellularvesiclesinurologicmalignanciesimplementationsforfuturecancercare AT wusong extracellularvesiclesinurologicmalignanciesimplementationsforfuturecancercare |